Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
3SBio
Welcome,
Profile
Billing
Logout
22 Products
12 Diseases
22 Products
45 Trials
517 News
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
2
4
6
8
10
12
14
16
18
20
Cipterbin
(inetetamab) / 3SBio
TPIAO
(recombinant human thrombopoietin) / 3SBio
Yisaipu
(etanercept biosimilar) / Cipla, 3SBio, Abbott
601A
/ 3SBio
EPIAO
(recombinant human erythropoietin biosimilar) / 3SBio
609A
/ 3SBio
611
/ 3SBio
Aybintio
(bevacizumab biosimilar) / Samsung, Mundipharma
CMAB007
(omalizumab biosimilar) / Mabpharm Limited
SSGJ-610
/ 3SBio
recombinant humanized anti-IL17A monoclonal antibody injection
(608) / 3SBio
CMAB807
(denosumab biosimilar) / 3SBio
CPGJ-602
/ 3SBio
Remitch OD
(nalfurafine hydrochloride orally disintegrating tablet) / Toray, Japan Tobacco, Sumitomo Pharma
SSGJ-613
/ 3SBio
SSS17
/ 3SBio
pegerythropoietin injection
(RD01) / 3SBio
pegylated irinotecan
(SSS22) / 3SBio
ALT-P7
/ Alteogen
CMAB818
(ranibizumab biosimilar) / 3SBio
Lei Ning
(abatacept biosimilar) / 3SBio
Retuxira
(rituximab biosimilar) / 3SBio
SSGJ-705
/ 3SBio
